Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Kalkine 0
countryflagAU

Inhalerx Ltd

Healthcare AU IRX

0.048AUD
0.003(6.67%)

Last update at 2025-06-20T00:46:00Z

Day Range

0.040.05
LowHigh

52 Week Range

0.020.05
LowHigh

Fundamentals

  • Previous Close 0.04
  • Market Cap7.47M
  • Volume266625
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.41374M
  • Revenue TTM0.40M
  • Revenue Per Share TTM0.002
  • Gross Profit TTM 0.40M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -1.89661M -1.11113M -1.01134M -2.27266M -1.74922M
Minority interest - - - - 0.05M
Net income -1.89661M -1.11113M -1.01134M -2.27266M -1.67572M
Selling general administrative 0.51M 0.56M 0.31M 0.79M 1.42M
Selling and marketing expenses 0.03M 0.05M 0.04M 0.05M -
Gross profit 0.02M 0.05M -0.02643M 0.05M 0.35M
Reconciled depreciation 0.00052M 0.00181M - 0.06M 0.08M
Ebit -1.92366M -1.12590M -1.20557M -1.64049M -1.92785M
Ebitda -1.92314M -1.12409M -1.02120M -1.57933M -1.87788M
Depreciation and amortization 0.00052M 0.00181M - 0.06M -
Non operating income net other - - - - -
Operating income -1.92366M -1.12590M -1.02120M -1.64049M -1.95937M
Other operating expenses 1.95M 1.29M 1.12M 2.15M 0.28M
Interest expense - 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M -0.02660M
Interest income 0.02M 0.00033M 0.00029M 0.02M 0.05M
Net interest income 0.02M 0.00033M 0.00029M 0.02M 0.05M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.01613M -0.00033M - 0.44M -0.02660M
Total revenue 0.02M 0.17M 0.10M 0.05M 0.35M
Total operating expenses 1.95M 1.18M 0.99M 2.15M -
Cost of revenue 0.00000M 0.12M 0.12M 0.17M 0.20M
Total other income expense net 0.01M 0.01M 0.00957M -0.18872M 0.16M
Discontinued operations - - - - -
Net income from continuing ops -1.89661M -1.11113M -1.20528M -2.38774M -1.72263M
Net income applicable to common shares -1.92705M -1.11113M -1.20528M -2.38774M -1.67572M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 0.65M 1.58M 2.26M 2.93M 1.90M
Intangible assets - - 0.01M 0.01M 0.00430M
Earning assets - - - - -
Other current assets 0.45M 0.06M -0.00000M 0.00108M 0.00240M
Total liab 0.78M 0.91M 0.36M 0.25M 0.58M
Total stockholder equity -0.13068M 1.00M 1.90M 2.68M 1.32M
Deferred long term liab - - - - -
Other current liab 0.17M 0.17M 0.26M 0.18M 0.46M
Common stock 14.53M 14.08M 13.93M 12.90M 10.56M
Capital stock - - 13.93M 12.90M 10.45M
Retained earnings -14.44525M -13.16916M -11.69545M -9.25430M -7.94924M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.19M 0.72M 2.13M 2.80M 1.72M
Cash and equivalents - - 2.13M 2.80M 1.72M
Total current liabilities 0.78M 0.91M 0.36M 0.25M 0.58M
Current deferred revenue - - - - -
Net debt -0.16085M -0.15554M -2.13339M -2.80348M -1.71948M
Short term debt 0.03M 0.56M 0.00000M 0.00000M 0.00000M
Short long term debt - - - - -
Short long term debt total 0.03M 0.56M - - -
Other stockholder equity 0.00000M - -0.02523M -0.96899M -0.29476M
Property plant equipment - - 0.00000M 0.00971M -
Total current assets 0.65M 1.58M 2.24M 2.91M 1.90M
Long term investments - - - - -
Net tangible assets - - 1.91M 2.66M 1.32M
Short term investments - - - - -
Net receivables - 0.80M 0.03M 0.02M 0.12M
Long term debt - - - - -
Inventory - - 0.08M 0.02M 0.04M
Accounts payable 0.57M 0.18M 0.10M 0.07M 0.12M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.21261M 0.09M -0.30408M -0.96899M -0.98781M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total - - 0.01M 0.02M 0.00430M
Capital lease obligations - - - - -
Long term debt total - - 0.00000M 0.00000M 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.00017M -0.02509M -0.00430M -0.03634M -0.13704M
Change to liabilities 0.08M -0.11604M 0.10M -0.12470M -0.36129M
Total cashflows from investing activities -0.00018M -0.02509M -0.00430M -0.03634M -0.13704M
Net borrowings - - - - -
Total cash from financing activities 1.18M 2.26M 2.37M 2.37M 2.37M
Change to operating activities -0.01439M 0.04M -0.07066M -0.01181M -0.01030M
Net income -1.89661M -1.11113M -1.20528M -2.38774M -1.67572M
Change in cash -0.67009M 1.08M 1.29M -1.88955M -2.20150M
Begin period cash flow 2.80M 1.72M 0.42M 2.31M 4.52M
End period cash flow 2.13M 2.80M 1.72M 0.42M 2.31M
Total cash from operating activities -1.84630M -1.14857M -1.04924M -1.86618M -2.06447M
Issuance of capital stock 1.20M 2.27M 2.41M - -
Depreciation 0.00052M 0.00181M 0.00181M 0.06M 0.03M
Other cashflows from investing activities - - - 0.00000M -0.03788M
Dividends paid - - - - -
Change to inventory - -0.02060M -0.02060M -0.02060M -
Change to account receivables - 0.06M 0.09M 0.06M 0.08M
Sale purchase of stock -0.02362M -0.01377M 2.41M - -
Other cashflows from financing activities -0.00017M -0.02509M -0.03653M -0.03634M -0.03653M
Change to netincome 0.05M 0.00430M 0.03M 0.54M -0.16537M
Capital expenditures 0.00017M 0.03M 0.00430M 0.04M 0.09M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.02M 0.00033M 0.01M 0.11M 0.06M
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow -0.00017M -0.02509M -0.00430M -0.03634M -2.16363M

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
IRX
Inhalerx Ltd		 0.003 6.67% 0.05 - - 21.25 9.12 273.62 -3.5284
CSL
CSL Ltd		 1.50 0.63% 240.21 28.64 32.15 7.65 4.04 5.81 18.03
TLX
Telix Pharmaceuticals Ltd		 -0.08 0.32% 24.92 166.67 57.47 10.68 14.73 10.52 89.03
MSB
Mesoblast Ltd		 -0.03 1.80% 1.64 - 454.55 367.78 2.98 67.90 -9.8623
NEU
Neuren Pharmaceuticals Ltd		 0.10 0.80% 12.54 11.61 75.76 7.37 4.49 6.61 8.03

Reports Covered

Stock Research & News

View All

Profile

InhaleRx Limited, a biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia. It is developing IRX-211 that has completed Phase 1 clinical trial for the treatment of Breakthrough Cancer Pain (BTcP); and IRX-616a that is in preclinical trial for panic disorder (PD). The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is headquartered in Melbourne, Australia.

Inhalerx Ltd

505 Little Collins Street, Melbourne, VIC, Australia, 3000

Key Executives

Name Title Year Born
Mr. Darryl Davies Chief Exec. Officer NA
Dr. Robert Jenny Ph.D. Chief Scientific Officer NA
Mr. Srinivasa Rao Suryadevara Exec. VP 1968
Ms. Nova Anne Taylor Company Sec. NA
Ms. Elizabeth Spooner Joint Company Sec. NA
Mr. Darryl Davies B.Sc. Chief Executive Officer NA
Dr. Robert Jenny B.A., B.Sc., Ph.D. Chief Scientific Officer NA
Mr. Srinivasa Rao Suryadevara Executive Vice President 1968
Mr. James Stephen Barrie CPA Company Secretary NA
Mr. Darryl Davies B.Sc. Chief Executive Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.